This review article critically examines the current literature for Dupuytren's disease.
Methods
Five procedures are considered: dermofasciectomy, limited fasciectomy, segmental aponeurectomy, needle aponeurotomy, and collagenase injection. Studies regarding the efficacy of these treatments focus primarily on the initial degree of correction, rate of recurrence, and complications.
Results
No one treatment has been declared superior and substantial controversy exists. Comparison between studies has been hampered by the absence of uniform definitions for clinical success and measurable disease progression. Traditional postoperative care includes formal therapy and night splinting, but recent studies have questioned the value of these adjuncts.
Conclusion
The extent of involvement at which the surgeon should intervene was previously well accepted by convention, but as the paradigm shifts towards less invasive procedures, treatment may be offered at an earlier stage. Future research should be structured to recognize the value-based decision making used by patients when selecting treatment.
AbeYRokkakuTOfuchiW. An objective method to evaluate the risk of recurrence and extension of Dupuytren's disease. J Hand Surg (Br).2004;29(5):427–30.
2.
ArmstrongJRHurrenJSLoganAM. Dermofasciectomy in the management of Dupuytren's disease. J Bone Joint Surg Br.2000;82(1):90–4.
3.
BadalamenteMAHurstLC. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J Hand Surg [Am].2000;25(4):629–36.
4.
BadalamenteMAHurstLC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg [Am].2007;32(6):767–74.
5.
BadalamenteMAHurstLCHentzVR. Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg [Am].2002;27(5):788–98.
6.
BainbridgeCGerberRASzczypaPP. Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture. J Plast Surg Hand Surg.2012;46(3–4):177–83.
7.
BalaguerTDavidSIhraiT. Histological staging and Dupuytren's disease recurrence or extension after surgical treatment: a retrospective study of 124 patients. J Hand Surg Eu.2009;34(4):493–6.
8.
BeckerGWDavisTR. The outcome of surgical treatments for primary Dupuytren's disease—a systematic review. J Hand Surg Eu.2010;35(8):623–6.
9.
BeyermannKPrommersbergerKJJacobsC. Severe contracture of the proximal interphalangeal joint in Dupuytren's disease: does capsuloligamentous release improve outcome?J Hand Surg (Br).2004;29(3):240–3.
10.
BuddHRLarsonDChojnowskiA. The QuickDASH score: a patient-reported outcome measure for Dupuytren's surgery. J Hand Ther.2011;24(1):15–20.
11.
BulstrodeNWJemecBSmithPJ. The complications of Dupuytren's contracture surgery. J Hand Surg [Am].2005;30(5):1021–5.
12.
ChenNCShauverMJChungKC. Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for Dupuytren contracture. J Hand Surg [Am].2011;36(11):1826–34.
13.
ChenNCSrinivasanRCShauverMJ. A systematic review of outcomes of fasciotomy, aponeurectomy, and collagenase treatments for Dupuytren's contracture. HAND.2011;6(3):250–5.
14.
CitronNHearndenA. Skin tension in the aetiology of Dupuytren's disease; a prospective trial. J Hand Surg (Br).2003;28(6):528–30.
15.
CitronNDNunezV. Recurrence after surgery for Dupuytren's disease: a randomized trial of two skin incisions. J Hand Surg (Br).2005;30(6):563–6.
16.
ClibbonJJLoganAM. Palmar segmental aponeurectomy for Dupuytren's disease with metacarpophalangeal flexion contracture. J Hand Surg (Br).2001;26(4):360–1.
17.
CoertJHNerinJPMeekMF. Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients. Ann Plast Surg.2006;57(1):13–7.
18.
CreanSMGerberRALe GraverandMP. The efficacy and safety of fasciectomy and fasciotomy for Dupuytren's contracture in European patients: a structured review of published studies. J Hand Surg Eu.2011;36(5):396–407.
19.
DenklerK. Surgical complications associated with fasciectomy for Dupuytren's disease: a 20-year review of the English literature. Eplasty.2010;10:116–33.
20.
DesaiSSHentzVR. The treatment of Dupuytren's disease. J Hand Surg [Am].2011;36(5):936–42.
21.
Di BenedettiDBNguyenDZografosL. Prevalence, incidence, and treatments of Dupuytren's disease in the United States: results from a population-based study. HAND.2011;6:149–58.
22.
DiasJJBraybrookeJ. Dupuytren's contracture: an audit of the outcomes of surgery. J Hand Surg (Br).2006;31(5):514–21.
23.
DonaldsonOWPearsonDReynoldsR. The association between intraoperative correction of Dupuytren's disease and residual postoperative contracture. J Hand Surg Eu.2010;35(3):220–3.
24.
EatonC. Percutaneous fasciotomy for Dupuytren's contracture. J Hand Surg [Am].2011;36:910–5.
25.
EbskovLBBoeckstynsMESorensenAI. Results after surgery for severe Dupuytren's contracture: does a dynamic extension splint influence outcome?Scand J Plast Reconstr Surg Hand Surg.2000;34(2):155–60.
26.
EvansRBDellPCFiolkowskiP. A clinical report of the effect of mechanical stress on functional results after fasciectomy for Dupuytren's contracture. J Hand Ther.2002;15(4):331–9.
27.
FoucherGMedinaJNavarroR. Percutaneous needle aponeurotomy: complications and results. J Hand Surg (Br).2003;28:427–31.
28.
GilpinDColemanSHallS. Injectable collagenase clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease. J Hand Surg [Am].2010;35(12):2027–38.
29.
HallPNFitzgeraldASterneGD. Skin replacement in Dupuytren's disease. J Hand Surg (Br).1997;22(2):193–7.
30.
HindochaSStanleyJKWatsonS. Dupuytren's diathesis revisited: evaluation of prognostic indicators for risk of disease recurrence. J Hand Surg [Am].2006;31(10):1626–34.
31.
HoviusSEKanHJSmitX. Extensive percutaneous aponeurotomy and lipografting: a new treatment for Dupuytren disease. Plast Reconstr Surg.2011;128(1):221–8.
32.
HurstLCBadalamenteMAHentzVR. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med.2009;361:968–79.
33.
Jerosch-HeroldCShepstoneLChojnowskiAJ. Severity of contracture and self-reported disability in patients with Dupuytren's contracture referred for surgery. J Hand Ther.2011;24(1):6–10.
34.
Jerosch-HeroldCShepstoneLChojnowskiAJ. Night-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren's contracture: a pragmatic, multi-centre, randomised controlled trial. BMC Musculoskeletal Disord.2011;12:136.
35.
McMillanCBinhammerP. Steroid injection and needle aponeurotomy for Dupuytren contracture: a randomized controlled study. J Hand Surg [Am].2012;37(7):1307–12.
36.
MisraAJainAGhazanfarR. Predicting the outcome of surgery for the proximal interphalangeal joint in Dupuytren's disease. J Hand Surg [Am].2007;32(2):240–5.
37.
MoermansJP. Long-term results after segmental aponeurectomy for Dupuytren's disease. J Hand Surg (Br).1996;21(6):797–800.
38.
PeimerCABlazarPColemanS. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data. J Hand Surg [Am].2013;38(1):12–22.
39.
PessGMPessRMPessRA. Results of needle aponeurotomy for Dupuytren contracture in over 1,000 fingers. J Hand Surg [Am].2012;37(4):651–6.
40.
RahrLSondergaardPBisgaardT. Percutaneous needle fasciotomy for primary Dupuytren's contracture. J Hand Surg Eu.2011;36(7):548–52.
41.
RoushTFSternPJ. Results following surgery for recurrent Dupuytren's disease. J Hand Surg [Am].2000;25(2):291–6.
42.
ShinEKJonesNF. Minimally invasive technique for release of Dupuytren's contracture: segmental fasciectomy through multiple transverse incisions. HAND.2011;6(3):256–9.
43.
SkoffHD. The surgical treatment of Dupuytren's contracture: a synthesis of techniques. Plast Reconstr Surg.2004;113(2):540–4.
44.
UllahASDiasJJBhowalB. Does a ‘firebreak’ full-thickness skin graft prevent recurrence after surgery for Dupuytren's contracture?: a prospective, randomised trial. J Bone Joint Surg Br.2009;91(3):374–8.
45.
Van RijssenALGerbrandyFSTer LindenH. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg [Am].2006;31(5):717–25.
46.
Van RijssenALTer LindenHWerkerPM. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg.2012;129(2):469–77.
47.
Van RijssenALWerkerPM. Percutaneous needle fasciotomy in Dupuytren's disease. J Hand Surg (Br).2006;31:498–501.
48.
Van RijssenALWerkerPMN. Percutaneous needle fasciotomy for recurrent Dupuytren Disease. J Hand Surg [Am].2012;37(9):1820–3.
49.
WattAJCurtinCMHentzVR. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up. J Hand Surg [Am].2010;35(4):534–9.
50.
WeinzweigNCulverJEFleeglerEJ. Severe contractures of the proximal interphalangeal joint in Dupuytren's disease: combined fasciectomy with capsuloligamentous release versus fasciectomy alone. Plast Reconstr Surg.1996;97(3):560–6.
51.
WilbrandSEkbomAGerdinB. The sex ratio and rate of reoperation for Dupuytren's contracture in men and women. J Hand Surg (Br).1999;24(4):456–9.
52.
WilbrandSFlodmarkCEkbomA. Activation markers of connective tissue in Dupuytren's contracture: relation to postoperative outcome. Scand J Plast Reconstr Surg Hand Surg.2003;37(5):283–92.
53.
WitthautJJonesGSkrepnikN. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies. J Hand Surg [Am].2013;38(1):2–11.
